C12N 2501/2314
Interleukin-14
Official title: Interleukin-14 (IL-14)
C12N2501/2314 (Interleukin-14) appears on 1 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 5
- Assignees
- 3
- Inventors
- 8
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Macrophage-derived engineered vesicles for targeted delivery and treatment13 Nov 2025US 2025/0345283 A1University of Kentucky Research Foundation
- Til expansion processes using specific cytokine combinations and/or akti treatment7 Nov 2024US 2024/0368547 A1Iovance Biotherapeutics, Inc.
- Til expansion processes using specific cytokine combinations and/or akti treatment28 Dec 2023US 2023/0416680 A1Iovance Biotherapeutics, Inc.
- Macrophage-derived engineered vesicles for targeted delivery and treatment9 Mar 2023US 2023/0071507 A1University of Kentucky Research Foundation
- Combination Treatment Of Induced Pluripotent Stem Cells Using Interleukins3 Feb 2022US 2022/0033771 A1So Young Life Sciences Corporation
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.